Talis Biomedical Corp
NASDAQ:TLIS
Talis Biomedical Corp
Revenue
Talis Biomedical Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
T
|
Talis Biomedical Corp
NASDAQ:TLIS
|
Revenue
$4.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
See Also
What is Talis Biomedical Corp's Revenue?
Revenue
4.8m
USD
Based on the financial report for Dec 31, 2022, Talis Biomedical Corp's Revenue amounts to 4.8m USD.
What is Talis Biomedical Corp's Revenue growth rate?
Revenue CAGR 3Y
7%
Over the last year, the Revenue growth was -41%. The average annual Revenue growth rates for Talis Biomedical Corp have been 7% over the past three years .